Privia Health Group, Inc. (NASDAQ:PRVA) Receives $27.77 Average Price Target from Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) have been assigned an average rating of "Buy" from the thirteen brokerages that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, eleven have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $27.77.

A number of analysts have recently issued reports on the stock. Needham & Company LLC reaffirmed a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. Robert W. Baird raised their price target on Privia Health Group from $24.00 to $26.00 and gave the company an "outperform" rating in a research report on Tuesday, April 15th. JMP Securities reiterated a "market outperform" rating and issued a $29.00 price objective on shares of Privia Health Group in a report on Monday, April 28th. Truist Financial increased their price objective on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Thursday, April 10th. Finally, JPMorgan Chase & Co. raised their price objective on Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a report on Wednesday, May 28th.

Insider Transactions at Privia Health Group

In related news, Director Matthew Shawn Morris sold 10,309 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $240,508.97. Following the sale, the director owned 59,792 shares in the company, valued at approximately $1,394,947.36. This trade represents a 14.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Parth Mehrotra sold 13,773 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $24.99, for a total transaction of $344,187.27. Following the completion of the transaction, the chief executive officer owned 423,143 shares in the company, valued at $10,574,343.57. This trade represents a 3.15% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,949 shares of company stock valued at $1,100,368 in the last ninety days. 10.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Proficio Capital Partners LLC bought a new position in Privia Health Group in the 4th quarter worth $464,000. US Bancorp DE boosted its position in shares of Privia Health Group by 6.7% during the 4th quarter. US Bancorp DE now owns 18,058 shares of the company's stock valued at $353,000 after acquiring an additional 1,134 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Privia Health Group by 108.1% in the fourth quarter. Smartleaf Asset Management LLC now owns 7,275 shares of the company's stock valued at $142,000 after purchasing an additional 3,779 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in Privia Health Group by 6.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,133,873 shares of the company's stock worth $22,167,000 after purchasing an additional 69,649 shares during the last quarter. Finally, Victory Capital Management Inc. raised its stake in Privia Health Group by 62.0% during the fourth quarter. Victory Capital Management Inc. now owns 290,009 shares of the company's stock valued at $5,670,000 after purchasing an additional 110,960 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Stock Performance

Privia Health Group stock traded down $0.62 during mid-day trading on Wednesday, hitting $21.92. 1,007,700 shares of the company traded hands, compared to its average volume of 814,803. Privia Health Group has a one year low of $16.47 and a one year high of $26.09. The stock has a market cap of $2.67 billion, a price-to-earnings ratio of 182.68, a price-to-earnings-growth ratio of 3.68 and a beta of 0.82. The stock has a fifty day moving average price of $23.16 and a 200-day moving average price of $22.88.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.